CARDIOCELL
Founded in San Diego, Calif., in 2013, CardioCell LLC is a global biotechnology company that explores therapeutic applications of unique patented ischemia-tolerant mesenchymal stem cells (itMSCs) manufactured under cGMP conditions. CardioCell has an exclusive worldwide license from its parent company, Stemedica, for exploration of therapeutic indications in the cardiovascular field, which includes such indications as acute myocardial Infarction (AMI), chronic heart failure (CHF) and peripheral artery disease (PAD).
CARDIOCELL
Industry:
Biotechnology Clinical Trials Health Care
Founded:
2013-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.stemcardiocell.com
Total Employee:
1+
Status:
Active
Contact:
(858) 875-6569
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Microsoft Exchange Online
Similar Organizations
ACS Global
ACS Global offers services for individuals to privately preserve their stem cells for potential future use in cell therapy.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.stemcardiocell.com Semrush global rank: 5.93 M Semrush visits lastest month: 1.39 K
- Host name: 104.21.44.141
- IP address: 104.21.44.141
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "CardioCell"
CardioCell - 2025 Company Profile & Team - Tracxn
CardioCell - Mesenchymal stem cells based therapy for different cardiovascular indications such as acute myocardial infarction.. Raised a total funding of $1.06M over 1 round.See details»
CardioCell Company Profile | Management and Employees List
CardioCell Profile and History Founded in San Diego, California, in 2013, CardioCell LLC is a global biotechnology company that explores therapeutic applications of unique, patented, …See details»
CardioCell - Overview, News & Similar companies | ZoomInfo.com
View CardioCell (www.stemcardiocell.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much …See details»
stemcardiocell.com
Stemcardiocell.comSee details»
CardioCell - LinkedIn
About us Website http://stemcardiocell.com Industry Biotechnology Company size 2-10 employees Headquarters San Diego, CASee details»
CardioCell 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for CardioCell. Use the PitchBook Platform to explore the full profile.See details»
CardioCell - Crunchbase Company Profile & Funding
CardioCell is currently in clinical trials using stem cells to develop highly effective, “off-the-shelf” therapeutic products.See details»
Cardiocell LLC - Drug pipelines, Patents, Clinical trials - Synapse
Explore Cardiocell LLC with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 2 news, and 1 literature, Drug:Mesenchymal stem cell therapy (Stemedica Cell …See details»
CardioCell Company Profile - Craft
See insights on CardioCell including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
CardioCell (Stemedica) - Regenerative Medicine Now
CardioCell LLC is a global biotechnology company that explores therapeutic applications of unique patented ischemia-tolerant mesenchymal stem cells (itMSCs) manufactured under …See details»
CardioCell Plans Phase IIb Clinical Trial Using Its Stem Cells for ...
Dec 1, 2015 For more information, visit www.stemcardiocell.com. About Stemedica Cell Technologies, Inc. Stemedica Cell Technologies, Inc. is a global biopharmaceutical company …See details»
New Stem Cell Therapy May Transform Heart Failure Treatment
Washington, D.C., April 18, 2018 – Clinical trial planning is underway at MedStar Heart & Vascular Institute to determine whether a novel stem cell therapy will improve heart function …See details»
Cardiac stem cells: Current knowledge and future prospects
Regenerative medicine is the field concerned with the repair and restoration of the integrity of damaged human tissues as well as whole organs. Since the inception of the field several …See details»
CardioCell stem cells ‘improve well-being’ of heart failure patients
Aug 29, 2016 Since Celyad failed to reach its primary endpoints in a stem cell therapy test in heart patients back in June, CardioCell has felt the pressure to deliver and over the weekend …See details»
Stem cells and the heart—the road ahead - Science | AAAS
Feb 21, 2020 Heart disease is the primary cause of death worldwide, principally because the heart has minimal ability to regenerate muscle tissue. Myocardial infarction (heart attack) …See details»
CardioCell Completes Enrollment For A Phase IIa Clinical
For more information, visit www.stemcardiocell.com. About Stemedica Cell Technologies Inc. Stemedica Cell Technologies Inc. is a global biopharmaceutical company that manufactures …See details»
Stem cell therapy for cardiac regeneration: past, present, and future
Cardiac disorders remain the leading cause of mortality worldwide. Current clinical strategies, including drug therapy, surgical interventions, and organ transplantation offer limited benefits …See details»
Cardiac stem cell biology: a glimpse of the past, present, and future
Cardiac regeneration strategies and de novo generation of cardiomyocytes have long been significant areas of research interest in cardiovascular medicine. In this review, we outline a …See details»
The Adult Cardiac Stem Cell Concept and the Process of Science
One theory of the mammalian heart has been that cardiomyocytes arose from adult stem cells marked by the cell surface protein Sca-1. In this issue of Circulation, five reports from different …See details»
Cardioids reveal self-organizing principles of human cardiogenesis
May 20, 2021 However, existing models do not recapitulate cardiac-specific self-organization to acquire in vivo -like architecture such as a CM chamber with inner endocardial cavity lining …See details»